Vera Paar

1.0k total citations
73 papers, 731 citations indexed

About

Vera Paar is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Rheumatology. According to data from OpenAlex, Vera Paar has authored 73 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 22 papers in Immunology and 15 papers in Rheumatology. Recurrent topics in Vera Paar's work include Cardiovascular Function and Risk Factors (16 papers), GDF15 and Related Biomarkers (14 papers) and Heart Failure Treatment and Management (13 papers). Vera Paar is often cited by papers focused on Cardiovascular Function and Risk Factors (16 papers), GDF15 and Related Biomarkers (14 papers) and Heart Failure Treatment and Management (13 papers). Vera Paar collaborates with scholars based in Austria, Germany and Russia. Vera Paar's co-authors include Uta C. Hoppe, Michael Lichtenauer, Bernhard Wernly, Christian Jung, Daniel Kretzschmar, Peter Jirak, Lukas J. Motloch, P. Christian Schulze, Moritz Mirna and Rudin Pistulli and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Vera Paar

66 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Paar Austria 17 349 157 153 101 97 73 731
Rudin Pistulli Germany 16 352 1.0× 132 0.8× 196 1.3× 77 0.8× 86 0.9× 53 716
Ilonka Rohm Germany 15 283 0.8× 135 0.9× 192 1.3× 66 0.7× 79 0.8× 31 654
Annie Poon United States 17 173 0.5× 213 1.4× 165 1.1× 132 1.3× 106 1.1× 28 876
Jie Geng China 15 210 0.6× 253 1.6× 100 0.7× 35 0.3× 151 1.6× 48 806
Jacqueline Smith United Kingdom 17 187 0.5× 135 0.9× 183 1.2× 383 3.8× 91 0.9× 34 809
Michael Schwarzl Germany 15 464 1.3× 201 1.3× 90 0.6× 38 0.4× 203 2.1× 28 819
Yuki Honda Japan 13 308 0.9× 133 0.8× 46 0.3× 38 0.4× 74 0.8× 30 595
Steven Pfau United States 14 262 0.8× 276 1.8× 490 3.2× 72 0.7× 117 1.2× 31 1.1k
Barry Ticho United States 14 527 1.5× 244 1.6× 157 1.0× 64 0.6× 64 0.7× 27 1.5k
Carsten Wunderlich Germany 19 571 1.6× 256 1.6× 42 0.3× 57 0.6× 196 2.0× 63 1.2k

Countries citing papers authored by Vera Paar

Since Specialization
Citations

This map shows the geographic impact of Vera Paar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Paar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Paar more than expected).

Fields of papers citing papers by Vera Paar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Paar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Paar. The network helps show where Vera Paar may publish in the future.

Co-authorship network of co-authors of Vera Paar

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Paar. A scholar is included among the top collaborators of Vera Paar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Paar. Vera Paar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edlinger, Christoph, et al.. (2026). Next-generation biomarkers for short term risk stratification in tricuspid valve intervention. Biomarkers in Medicine. 20(2). 129–139.
2.
3.
Jirak, Peter, Vera Paar, Albert Topf, et al.. (2025). Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study. Journal of Clinical Medicine. 14(16). 5668–5668. 1 indexed citations
4.
Edlinger, Christoph, Michael Lichtenauer, Vera Paar, et al.. (2024). Growth Differentiation Factor 15 as a Marker for Chronic Ventricular Pacing. Journal of Clinical Medicine. 13(24). 7748–7748. 1 indexed citations
5.
Edlinger, Christoph, Vera Paar, Michael Lichtenauer, et al.. (2024). Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation. Heart Rhythm O2. 5(11). 770–777.
6.
7.
Jirak, Peter, Moritz Mirna, Richard Rezar, et al.. (2022). A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease. Applied Sciences. 12(3). 1419–1419. 5 indexed citations
8.
Rezar, Richard, Michael Lichtenauer, Vera Paar, et al.. (2022). Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest. Cells. 11(21). 3367–3367. 2 indexed citations
9.
Lenz, Max, Robert Schönbauer, Stefan Stojković, et al.. (2022). RANTES and CD40L under Conditions of Long-Term Physical Exercise: A Potential Link to Adaptive Immunity. International Journal of Environmental Research and Public Health. 19(14). 8658–8658. 2 indexed citations
10.
Jirak, Peter, Vera Paar, Richard Rezar, et al.. (2021). Promising Novel Biomarkers in Cardiovascular Diseases. Applied Sciences. 11(8). 3654–3654. 5 indexed citations
11.
Topf, Albert, Moritz Mirna, Vera Paar, et al.. (2021). Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies. Frontiers in Cardiovascular Medicine. 8. 700169–700169. 4 indexed citations
12.
Topf, Albert, Moritz Mirna, Vera Paar, et al.. (2021). The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome. Clinical Research in Cardiology. 111(2). 197–206. 12 indexed citations
13.
Mirna, Moritz, Alexander Lauten, Peter Jirak, et al.. (2020). Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR). European Journal of Internal Medicine. 85. 98–107. 2 indexed citations
14.
Mirna, Moritz, Albert Topf, Bernhard Wernly, et al.. (2020). Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study. Journal of Clinical Medicine. 9(3). 886–886. 19 indexed citations
15.
Jirak, Peter, Rudin Pistulli, Michael Lichtenauer, et al.. (2020). Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls. Journal of Clinical Medicine. 9(4). 1130–1130. 22 indexed citations
16.
Mirna, Moritz, Vera Paar, Richard Rezar, et al.. (2019). MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?. Cells. 8(11). 1352–1352. 49 indexed citations
17.
Lichtenauer, Michael, Bernhard Wernly, Vera Paar, et al.. (2018). Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity. Journal of Investigative Medicine. 67(5). 833–840. 9 indexed citations
18.
Edlinger, Christoph, Michael Lichtenauer, Bernhard Wernly, et al.. (2018). Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease. Heart and Vessels. 34(6). 976–983. 18 indexed citations
19.
Muessig, Johanna M., Michael Lichtenauer, Bernhard Wernly, et al.. (2018). Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI). International Journal of Cardiology. 277. 54–59. 16 indexed citations
20.
Schernthaner, Christiana, Vera Paar, Bernhard Wernly, et al.. (2017). Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction. Medicine. 96(44). e8396–e8396. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudin Pistulli Breakdown of academic impact, for papers by Ilonka Rohm Breakdown of academic impact, for papers by Annie Poon Breakdown of academic impact, for papers by Jie Geng Breakdown of academic impact, for papers by Jacqueline Smith Breakdown of academic impact, for papers by Michael Schwarzl Breakdown of academic impact, for papers by Yuki Honda Breakdown of academic impact, for papers by Steven Pfau Breakdown of academic impact, for papers by Barry Ticho Breakdown of academic impact, for papers by Carsten Wunderlich
Rankless by CCL
2026